AU2001286613A1 - Tissue engineering scaffolds promoting matrix protein production - Google Patents

Tissue engineering scaffolds promoting matrix protein production

Info

Publication number
AU2001286613A1
AU2001286613A1 AU2001286613A AU8661301A AU2001286613A1 AU 2001286613 A1 AU2001286613 A1 AU 2001286613A1 AU 2001286613 A AU2001286613 A AU 2001286613A AU 8661301 A AU8661301 A AU 8661301A AU 2001286613 A1 AU2001286613 A1 AU 2001286613A1
Authority
AU
Australia
Prior art keywords
protein production
tissue engineering
matrix protein
engineering scaffolds
promoting matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286613A
Inventor
Brenda K. Mann
Jennifer L. West
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
William Marsh Rice University
Original Assignee
William Marsh Rice University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Marsh Rice University filed Critical William Marsh Rice University
Publication of AU2001286613A1 publication Critical patent/AU2001286613A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent
AU2001286613A 2000-08-21 2001-08-21 Tissue engineering scaffolds promoting matrix protein production Abandoned AU2001286613A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22677100P 2000-08-21 2000-08-21
US60/226,771 2000-08-21
PCT/US2001/026170 WO2002016557A2 (en) 2000-08-21 2001-08-21 Tissue engineering scaffolds promoting matrix protein production

Publications (1)

Publication Number Publication Date
AU2001286613A1 true AU2001286613A1 (en) 2002-03-04

Family

ID=22850332

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286613A Abandoned AU2001286613A1 (en) 2000-08-21 2001-08-21 Tissue engineering scaffolds promoting matrix protein production

Country Status (5)

Country Link
US (3) US7635592B2 (en)
EP (1) EP1311657A2 (en)
JP (1) JP2004507237A (en)
AU (1) AU2001286613A1 (en)
WO (1) WO2002016557A2 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166464B2 (en) * 2001-12-11 2007-01-23 Cytograft Tissue Engineering, Inc. Method of culturing cells to produce a tissue sheet
WO2005041987A1 (en) * 2003-10-29 2005-05-12 Gentis, Inc. Polymerizable emulsions for tissue engineering
JP4585790B2 (en) * 2004-03-27 2010-11-24 独立行政法人科学技術振興機構 Cell culture scaffold and cell culture method
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
US20070087033A1 (en) * 2005-10-14 2007-04-19 Sigg Daniel C Self-fixating scaffolds
EP2347774B1 (en) 2005-12-13 2017-07-26 The President and Fellows of Harvard College Scaffolds for cell transplantation
US9782258B2 (en) * 2006-09-08 2017-10-10 The Regents Of The University Of California Intramyocardial patterning for global cardiac resizing and reshaping
KR100816395B1 (en) * 2006-09-21 2008-03-27 (주)필미아젠 Method for preparing a cell-derived extracellular matrix membrane
US20100189712A1 (en) * 2006-11-17 2010-07-29 Cytograft Tissue Engineering, Inc. Preparation And Use Of Cell-Synthesized Threads
US20080188936A1 (en) * 2007-02-02 2008-08-07 Tornier, Inc. System and method for repairing tendons and ligaments
US8529951B1 (en) * 2007-02-21 2013-09-10 Anand Ramamurthi Elastogenic cues and methods for using same
EP2146667A2 (en) * 2007-04-11 2010-01-27 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
WO2008154033A2 (en) * 2007-06-11 2008-12-18 Symphony Medical, Inc. Cardiac patterning for improving diastolic function
US9770535B2 (en) 2007-06-21 2017-09-26 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
WO2009102465A2 (en) 2008-02-13 2009-08-20 President And Fellows Of Harvard College Continuous cell programming devices
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
US20090270299A1 (en) * 2008-04-23 2009-10-29 Nissan Chemical Industries, Ltd. Composition for removing protective layer in fabrication of MEMS and method for removing same
WO2010005753A1 (en) * 2008-06-16 2010-01-14 Cytograft Tissue Engineering, Inc. Arterial implants
BRPI0919919A2 (en) 2008-10-21 2017-05-30 Massachusetts Gen Hospital cell transplant
DE102009005307B4 (en) * 2009-01-16 2011-06-01 Waldemar Knittel Glasbearbeitungs Gmbh slides
WO2010120749A2 (en) 2009-04-13 2010-10-21 President And Fellow Of Harvard College Harnessing cell dynamics to engineer materials
AU2010278702C1 (en) 2009-07-31 2016-07-14 Forsyth Dental Infirmary For Children Programming of cells for tolerogenic therapies
EP2491113B1 (en) 2009-10-23 2017-04-19 Arkansas State University Methods and compositions for enhancing polypeptide production
KR101122163B1 (en) * 2009-12-01 2012-03-16 (주)셀인바이오 Hyaluronic acid derivative with atopic dermatitis treating effect and method of preparing the same
EP2542230A4 (en) 2010-03-05 2013-08-28 Harvard College Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
US9693954B2 (en) 2010-06-25 2017-07-04 President And Fellows Of Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
JP6072684B2 (en) 2010-08-06 2017-02-01 ザ ジェネラル ホスピタル コーポレーション ディー／ビー／エイ マサチューセッツ ジェネラル ホスピタル Cell treatment system and cell treatment apparatus
SI2624873T1 (en) 2010-10-06 2020-07-31 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
EP2661243B1 (en) 2011-01-06 2022-10-12 Humacyte, Inc. Tissue-engineered constructs
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
US8673323B2 (en) 2011-01-07 2014-03-18 Washington University Polymer nanofiber scaffold for a heparin / fibrin based growth factor delivery system
US8936650B2 (en) 2011-03-23 2015-01-20 The Regents Of The University Of California Mesh enclosed tissue constructs
US10610616B2 (en) 2011-03-23 2020-04-07 The Regents Of The University Of California Mesh enclosed tissue constructs
US9968446B2 (en) 2011-03-23 2018-05-15 The Regents Of The University Of California Tubular scaffold for fabrication of heart valves
US9925296B2 (en) 2011-03-23 2018-03-27 The Regents Of The University Of California Mesh enclosed tissue constructs
EP2701753B1 (en) 2011-04-27 2018-12-26 President and Fellows of Harvard College Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
US10045947B2 (en) 2011-04-28 2018-08-14 President And Fellows Of Harvard College Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
CA2838125A1 (en) 2011-06-03 2012-12-06 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
WO2012167079A2 (en) 2011-06-03 2012-12-06 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
AU2012298791B2 (en) * 2011-08-25 2015-09-24 Allergan Industrie, Sas Dermal filler compositions including antioxidants
PT2838515T (en) 2012-04-16 2020-02-25 Harvard College Mesoporous silica compositions for modulating immune responses
JP7348708B2 (en) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Combination vaccine device and method for killing cancer cells
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2016123573A1 (en) 2015-01-30 2016-08-04 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
CN114099793A (en) 2015-04-10 2022-03-01 哈佛学院院长等 Immune cell capture device and methods of making and using same
CN115487351A (en) 2016-02-06 2022-12-20 哈佛学院校长同事会 Remodeling hematopoietic niches to reconstitute immunity
CN115305229A (en) 2016-07-13 2022-11-08 哈佛学院院长等 Antigen presenting cell mimetic scaffolds and methods of making and using same
CN111714248A (en) * 2020-05-08 2020-09-29 南开大学 Vascular stent for promoting rapid cell proliferation and extracellular matrix deposition and acellular matrix artificial blood vessel

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3245796A (en) * 1962-10-25 1966-04-12 Du Pont Photopolymerizable elements and processes
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
JPH07500315A (en) 1991-05-10 1995-01-12 セルトリックス　ファーマシューティカルズ，インコーポレイテッド Targeted delivery of bone growth factors
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
WO1994001483A1 (en) * 1992-07-02 1994-01-20 Collagen Corporation Biocompatible polymer conjugates
NO940913L (en) 1993-03-26 1994-09-27 Bristol Myers Squibb Co Controlled Release Preparations of Biologically Active TGF
AU6586394A (en) 1993-04-22 1994-11-08 Celtrix Pharmaceuticals, Inc. Conjugates of growth factor and bone resorption inhibitor
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
EP0705298B1 (en) * 1993-12-01 2002-03-27 Bioartificial Gel Technologies Inc. Albumin based hydrogel
US5686091A (en) * 1994-03-28 1997-11-11 The Johns Hopkins University School Of Medicine Biodegradable foams for cell transplantation
US5935849A (en) * 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US7008634B2 (en) * 1995-03-03 2006-03-07 Massachusetts Institute Of Technology Cell growth substrates with tethered cell growth effector molecules
US5916585A (en) * 1996-06-03 1999-06-29 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto biodegradable polymers
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions

Also Published As

Publication number Publication date
EP1311657A2 (en) 2003-05-21
JP2004507237A (en) 2004-03-11
US7635592B2 (en) 2009-12-22
WO2002016557A3 (en) 2003-01-03
US20050158357A1 (en) 2005-07-21
WO2002016557A2 (en) 2002-02-28
US20020106793A1 (en) 2002-08-08
US20050158358A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
AU2001286613A1 (en) Tissue engineering scaffolds promoting matrix protein production
GB0121985D0 (en) Tissue engineering scaffolds
AU2001280796A1 (en) Electrowetting-driven micropumping
AUPR773901A0 (en) Fracture cuff
AU2001289684A1 (en) Glass-ceramics, process for their preparation and use
AU2002220553A1 (en) Bioreactor
AU2002224553A1 (en) Human proteases
AU2002244230A1 (en) Concrete form system
AU2002214978A1 (en) Beta-Thio-amino acids
AU2001245489A1 (en) Human single nucleotide polymorphisms
AU2000261996A1 (en) Architectural molding
AU2001258533A1 (en) Construction of dies
AU5394300A (en) Tissue engineering
AU2002218440A1 (en) New process
AU2001284047A1 (en) Butinol I esterase
AU2001267769A1 (en) Process
AU2001292601A1 (en) Human matrix metalloproteinase
AU2002226319A1 (en) Human lysosomal acid lipase
AU2001264869A1 (en) Human secreted protein, zsig47
AU2001288231A1 (en) Human secreted protein, zzp1
AU2355501A (en) Bone cement
AU2000276980A1 (en) Production of concrete
AU2002324175A1 (en) Tissue engineering scaffolds
AU5052701A (en) Block construction
AU2001293825A1 (en) Hollow block